⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC USA - English APAC - English APAC -
prnewswire.com
MRK
Sterility Testing Market to Reach US$ 3,913.35 Million by 2035 Amid Rising Global Clinical Trial Activity Says Astute Analytica
globenewswire.com
CRL
AMGN
MRK
JNJ
STEM
PCI
NCLH
BioInvent Reports Promising Data from Ongoing Phase 2a study for BI-1808 with KEYTRUDA(R) (pembrolizumab) in Recurrent Ovarian Cancer
accessnewswire.com
MRK
3 Day Pharma Mini MBA Training Course (Mar 18th - Mar 20th, 2026) - ResearchAndMarkets.com
businesswire.com
PFE
MRK
JNJ
GSK
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading Players - Danaher, Merck, Sartorius, Solventum, and Repligen - ResearchAndMarkets.com
businesswire.com
DHR
MRK
SOLV
RGEN
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic Collaborations - ResearchAndMarkets.com
businesswire.com
MRK
BMY
AZN
JNJ
NVS
Debbie's Dream Foundation: Curing Stomach Cancer Thanks Its 2025 Industry Partners for Advancing Critical Programs and Patient Support
prnewswire.com
AMGN
BMY
ARCX
AZN
GILD
JAZZ
LLY
MRK
ASTL
THTX
Cell Therapy Technologies Market is expected to generate a revenue of USD 8.4 Billion by 2032, Globally, at 4.4% CAGR: Verified Market Research®
globenewswire.com
BDX
GEHC
LNN
MRK
TMO
AVTR
FMS
Etiome Strengthens Leadership Team with Appointment of Jean Lachowicz as Chief Scientific Officer
prnewswire.com
SDGR
MRK
Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor
globenewswire.com
MRK